Sandy Spring Bank Chroma Dex Corp. Transaction History

Sandy Spring Bank

$2.33 Billion
Q1 2025

A detailed history of Sandy Spring Bank transactions in Chroma Dex Corp. stock. As of the latest transaction made, Sandy Spring Bank holds 50 shares of CDXC stock, worth $307. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$307

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 12, 2025	BUY	$5.26 - $8.55 $263 - $427	50 New	50 $0
Q3 2021 Nov 05, 2021	BUY	$6.05 - $10.41 $21,175 - $36,435	3,500 New	3,500 $22,000

Others Institutions Holding CDXC

# of Institutions

175

Shares Held

30.9M

Call Options Held

121K

Put Options Held

55.6K

Vanguard Group Inc Valley Forge, PA

4.02M
Shares

$24.7 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.12M
Shares

$19.1 Million
0.0% of portfolio
Tieton Capital Management, LLC Yakima, WA

1.65M
Shares

$10.1 Million
4.08% of portfolio
Arrowstreet Capital, Limited Partnership Boston, MA

1.44M
Shares

$8.82 Million
0.01% of portfolio
Geode Capital Management, LLC Boston, MA

1.3M
Shares

$7.95 Million
0.0% of portfolio

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $420M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.

Account